马赛克HIV-1疫苗和SHIV挑战菌株V2循环序列的身份和灵长类动物的保护
Kanika Vanshylla1, Jeroen Tolboom1, Kathryn E Stephenson2,3,4
1Janssen Vaccines & Prevention, Leiden, The Netherlands.
NPJ vaccines
|September 30, 2024
概括
马赛克HIV-1疫苗在人类中的有效性失败了,但临床前研究表明灵长类动物具有高保护性. 分析发现V2循环是关键的,高疫苗挑战序列相同性可能解释了灵长类动物的保护.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
背景情况:
- 一种马赛克猿人免疫缺陷病毒 (SHIV) 疫苗的临床前研究表明,它在灵长类动物中具有很高的疗效.
- 同一个马赛克HIV-1疫苗的人类疫苗疗效试验最终失败了.
- 这种差异引发了关于临床前灵长类动物模型对人类HIV-1疫苗开发的可翻译性的问题.
研究的目的:
- 进行NHP13-19研究的后期免疫相关分析.
- 识别用马赛克HIV-1疫苗接种的灵长类动物中与保护相关的特定免疫反应.
- 调查V2循环在观察到的保护中的作用.
主要方法:
- 来自NHP13-19研究的HIV-1 Env结合抗体反应的分析.
- 在Mos1疫苗Env组件和SHIV挑战菌株之间的序列标识比较.
- 在Mos1疫苗Env组件和全球流通的HIV-1序列之间进行序列标识比较.
主要成果:
- 确定V2循环是灵长类动物保护的主要相关因子.
- 在Mos1疫苗和SHIV挑战菌株之间观察到高V2循环序列相同性.
- 该疫苗的V2循环序列相同性与全球流通的HIV-1序列相比明显较低.
结论:
- 针对V2循环的免疫反应的诱导可能解释了灵长类动物中观察到的高保护.
- 疫苗的V2表位和挑战菌株的Env之间的异常序列一致性可能有助于保护灵长类动物.
- 研究结果表明,针对具有高同质性挑战菌株的特定表位的疫苗诱导免疫反应对于临床前模型的有效性至关重要.
更多相关视频
06:25Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
Published on: December 23, 2016
9.2K
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.5K
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
